IRD · Opus Genetics Inc
United States · RS rating 64 · As of 2026-10-14
| Price | 4.10 USD |
|---|---|
| 1-day change | -3.3% |
| RS rating (overall / 1M / 3M / 12M) | 64 / 6 / 92 / 95 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 34 / 28 / 29 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | +89.3% |
| Sales growth Q/Q | +25.5% |
| Distance from 52-week high | +32.5% |
| Market cap (USD) | $372.0M |